EMA And Dutch Govt Eye July Signing Of Deal To Move Agency To Amsterdam
Executive Summary
The EMA and the Dutch authorities are expected to sign the agreement on the agency’s new home in Amsterdam on July 1. The agreement is aimed at ensuring the agency can function properly once it relocates, and describes how the Dutch government will treat the agency and its staff.
You may also be interested in...
EMA To Re-Prioritize Tasks To Cope With ‘Higher Than Expected’ Staff Losses
The EMA is to further refocus on its core activities to help it deal with “higher than expected” staff losses due to its relocation to Amsterdam.
UK In Major Move To Boost Commercial Clinical Trials & Improve Life Sciences Environment
The publication of two major reports has led the UK government to announce a £650m “Life Sci for Growth” package to bolster the life sciences sector.
UK Reveals Seven Partners Whose New Drug Approvals It Will Recognize
The UK regulator, the MHRA, says that while it will recognize drug approvals granted in the EU and a selection of other countries, it will remain a “sovereign regulator” with the ability to reject applications if they don’t meet its standards.